Citations 23

Meningitis as an Attack Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

JAMA Neurology | June 16, 2025 | Volume: 82 | Issue: 8 | Pages: 871

10.1001/jamaneurol.2025.1774 | PMID 40522676

This international multicenter study seeks to determine the frequency and characteristics of meningitis in myelin oligodendrocyte glycoprotein antibody (MOGAD)–associated disease and highlight its pathology.
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in Anti-LGI-1 Encephalitis (S7.002)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211378

Neighborhood Disadvantage is Not Associated with Exposure to NMOSD Treatment (P11-8.009)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210520

Immature Ovarian Teratomas in Anti-NMDA Receptor Encephalitis: A Case Series (P3-8.015)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211091

The Urgent Need for Evidence Over Anecdote: Equipoise in the ExTINGUISH Clinical Trial in Anti-NMDAR Encephalitis (P7-8.016)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000211728

Exploring Age-Dependent Differences in KLHL11 IgG Associated Paraneoplastic Rhombencephalitis (S18.007)

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000212184

Teaching Video NeuroImage: Perivascular Tumefactive Neurosarcoidosis of the Basal Ganglia

Neurology | September 16, 2024 | Volume: 103 | Issue: 8 | Pages: No page available

10.1212/wnl.0000000000209899 | PMID 39284110

Neighborhood disadvantage, race, and clinical outcomes in neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal | August 6, 2024 | Volume: 30 | Issue: 10 | Pages: 1322-1330

10.1177/13524585241267231 | PMID 39105475

Background: Little is known about the relationship between neighborhood disadvantage and neuromyelitis optica spectrum disorder (NMOSD) outcomes. Objective: The objective is to determine the impact of neighborhood disadvantage on time from symptom onset to diagnosis and annualized relapse rate (ARR). Methods: Neighborhood disadvantage were captured with the Area Deprivation Index (ADI), a validated measure of neighborhood-level disadvantage. Negative binomial regression models assessed the impact of ADI on diagnostic delay (⩾3 months between symptom onset and diagnosis) and ARR. Results: A total of 158 NMOSD patients were identified, a majority of whom were White (56.3%) and female (89.9%) with a mean age of 46 years at diagnosis. The ADI did not significantly affect odds of diagnostic delay (odds ratio (OR) = 0.99, p = 0.26). In univariable models, the ADI was not significantly associated with ARR (OR = 1.004, p = 0.29), but non-White race (OR = 1.541, p = 0.02) and time on immunosuppressive therapies (ISTs; OR = 0.994, p = 0.03) were. White patients used IST for an average of 81% of the follow-up period, compared to an average of 65% for non-White patients ( p < 0.01). Conclusion: No significant relationship between neighborhood-level disadvantage and diagnostic delay or ARR in NMOSD patients was observed. Non-White patients had a higher ARR, which may be related to less IST use.
Immune Checkpoint Inhibitor-associated Kelch-like Protein-11 IgG Rhombencephalitis (P3-14.002)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205023

Pediatric Adrenal Ganglioneuroma-associated Cerebellar Degeneration and Super-refractory Status Epilepticus (P3-14.007)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205830